Replies to post #114661 on Biotech Values

[mcbio]

We need to sprinkle some more small-cap biotech flavors in your diet. ; ) Outside of MNTA, where I of course agree with you, care to venture a guess on a couple of small-cap biotech names (say, sub-$1B market cap) that look interesting to you from a risk-reward perspective?

[DewDiligence]

[OT]—Corny title for DE’s blowout results reported today:

http://www.thestreet.com/print/story/11010683.html

:- )

[DewDiligence]

[OT]—CLF is an intriguing company in the natural-resources arena (#msg-60141717, #msg-60141751).

[DewDiligence]

My Top-20 Picks for LTBH

Each of these companies is a beneficiary of The Global Demographic Tailwind,
the premiere investing theme in the world today, IMO. Below is a sampler post
for each name. (Some samplers are older posts that are still a good read.)

 
 Stock    iHub Sampler 
 Pharma/healthcare: 
 ABT      #msg-60328021 
 AGN      #msg-59583715 
 MNTA     #msg-60525510 
 NVS      #msg-59333653 
 PFE      #msg-59590951 
 Natural resources: 
 BBL      #msg-60136197 
 CLB      #msg-59850719 
 CLF      #msg-58708254 
 CVX      #msg-41374691 
 HES      #msg-38256080 
 PCL      #msg-59586020 
 VALE     #msg-60355492 
 XOM      #msg-43578073 
 Industrial/technology: 
 APD      #msg-59079435 
 CUB      #msg-59585614 
 DE       #msg-59333090	 
 MMM      #msg-60356285 
 MON      #msg-60259277 
 UNP      #msg-58573323 
 Consumer staples: 
 HNZ      #msg-60572753 

Feedback welcome.